FDA — authorised 24 March 1969
- Status: approved
FDA authorised Ameparomo on 24 March 1969
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 24 March 1969; FDA authorised it on 14 December 2007.
Marketing authorisation holder not available in our data.